Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/01/2010EP2254857A1 Compositions and methods for treating ophthalmic diseases
12/01/2010EP2254666A1 2-aminoquinolines as 5-ht5a receptor antagonists
12/01/2010EP2254652A2 Local embolization via heating of thermosensitive polymers
12/01/2010EP2254640A2 Anti-infective catheters
12/01/2010EP2254606A2 Implant and method for the manufacture thereof
12/01/2010EP2254603A2 Methods for inhibiting six 1 and eya proteins
12/01/2010EP2254602A2 Continuous cell programming devices
12/01/2010EP2254597A2 Methods of treatment using anti-mif antibodies
12/01/2010EP2254591A2 Inhibition and treatment of gastrointestinal biofilms
12/01/2010EP2254584A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof
12/01/2010EP2254583A1 Anticancer agent
12/01/2010EP2254582A2 Methods of treating viral infections
12/01/2010EP2254581A1 Pteridine derivatives for treating respiratory disease
12/01/2010EP2254580A1 Methods for treating disorders using nmda nr2b-subtype selective antagonist
12/01/2010EP2254579A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
12/01/2010EP2254578A2 Combination of a carbostyril and carnitine
12/01/2010EP2254577A1 Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
12/01/2010EP2254576A1 Androgen receptot-ablative agents
12/01/2010EP2254575A2 Medicament
12/01/2010EP2254574A1 Beta-lactones as antibacterial agents
12/01/2010EP2254573A1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
12/01/2010EP2254572A2 Compounds that enhance atoh-1 expression
12/01/2010EP2254571A2 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
12/01/2010EP2254570A1 Combination comprising paclitaxel for treating ovarian cancer
12/01/2010EP2254569A1 Protopanaxadiol-type ginsenoside compositions and uses thereof
12/01/2010EP2254568A2 Methods and assays for detecting and treating hypoglycemia
12/01/2010EP2254567A2 Novel use of zinc n-acetyltaurinate
12/01/2010EP2254566A2 Kinase protein binding inhibitors
12/01/2010EP2254565A1 New use for cannabinoids
12/01/2010EP2254564A1 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
12/01/2010EP2254563A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
12/01/2010EP2254562A1 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety
12/01/2010EP2254558A1 Orally disintegrating tablets with speckled appearance
12/01/2010EP2254557A1 Methods to inhibit tumor cell growth by using proton pump inhibitors
12/01/2010EP2254556A2 Orally-disintegrating solid preparation
12/01/2010EP2254555A2 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
12/01/2010EP2254553A1 Abuse resistant melt extruded formulation having reduced alcohol interaction
12/01/2010EP2254552A1 Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate
12/01/2010EP2254551A2 Sterilized sucralfate gel
12/01/2010EP2254550A1 Pharmaceutical composition with gelling properties containing a tyrosine derivative
12/01/2010EP2254549A2 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/01/2010EP2254420A2 Cns pharmaceutical compositions and methods of use
12/01/2010EP2254415A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
12/01/2010EP2254413A1 Imidazobenzazepine cgrp receptor antagonists
12/01/2010EP2254412A1 Macrocyclic lactone compounds and methods for their use
12/01/2010EP2254410A1 Methods for inhibiting drug degradation
12/01/2010EP2186509B1 Propofol transparent anaesthetic solution with low venous irritation
12/01/2010EP2167046B1 Pharmaceutical solid preparation comprising benzazepines and production method thereof
12/01/2010EP2155179B1 Axomadol for treating pain from arthritis
12/01/2010EP2146951B1 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
12/01/2010EP2102164B1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
12/01/2010EP2082742B1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
12/01/2010EP2070538B1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
12/01/2010EP2040689B1 Solution comprising n-acetylcysteine and gluconic acid, and methods to reduce, treat and/or prevent oxidative stress and cell activation
12/01/2010EP2029574B1 Novel method for preparation of ammonium salts of esomeprazole
12/01/2010EP2004604B1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
12/01/2010EP1951721B1 3 -monosubstituted tropane derivative as nociceptin receptor ligand
12/01/2010EP1932832B1 Triarylcarboxylic acid derivative
12/01/2010EP1926483B1 Treatment of autoimmune diseases
12/01/2010EP1906926B1 Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole derivatives
12/01/2010EP1904494B1 Imidazo[1,2-a]pyridine compounds as vegf-r2 inhibitors
12/01/2010EP1896467B1 Tricyclic opioid modulators
12/01/2010EP1869020B1 Heteroaryl urea derivatives useful for inhibiting chk1
12/01/2010EP1853271B1 Method and composition for treating peripheral vascular diseases
12/01/2010EP1765850B1 Substituted propane phosphinic acid derivatives
12/01/2010EP1713445B1 Non-lamellar compositions of dioleoyl phosphatidylethanolamine and polysorbate 80
12/01/2010EP1711190B1 Agent for treating inflammatory diseases
12/01/2010EP1692516B1 Method of therapy
12/01/2010EP1663253B1 Formulations containing salicylates and their use for treating inflammatory bowel disease
12/01/2010EP1652928B1 Plant producing hyaluronic acid
12/01/2010EP1651649B1 Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medication
12/01/2010EP1569679B1 Chaperonin 10 immunosuppression
12/01/2010EP1535916B1 Inclusion complexes of butylphthalide with cyclodextrin derivatives and processes for their preparation
12/01/2010EP1487442B1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
12/01/2010EP1414996B1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/01/2010EP1399176B1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010EP1322156B3 Disinfectant
12/01/2010EP1284137B1 Nonoral preparation having three-layer structure
12/01/2010EP1263411B1 Compositions and use thereof for trapping and inactivating pathogenic microbes and spermatozoa
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010EP0857047B1 Formulation comprising eutectic mixture of tetracaine and lidocaine
12/01/2010CN201658672U Improved dogskin plaster
12/01/2010CN201657749U Resveratrol microcapsule
12/01/2010CN1993353B Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/01/2010CN1985850B Oral medicine composition for replenishing Ca, Mg and Fe and its preparing method and use
12/01/2010CN1982313B Camptothecin compound containing multiple organic hydroxy-acid group on 10-bit substituent, its production and composition
12/01/2010CN1946698B Pyrazole phenyl derivatives as ppar activators
12/01/2010CN1939472B Detection method of compound preparation for treating diabetes
12/01/2010CN1935192B Chinese medicine composition, and its preparing method and quality control method
12/01/2010CN1928112B Expression of VEGF I type receptor on blood vessel adventitia fibroblast
12/01/2010CN1926155B 羟乙基淀粉 Hydroxyethyl starch
12/01/2010CN1919253B Cardiac and cerebral vascular disease treating medicinal composition
12/01/2010CN1919235B Cardiac and cerebral vascular disease treating pharmaceutical composition
12/01/2010CN1913896B Methods and compositions for the treatment and management of hemoglobinopathy and anemia
12/01/2010CN1897975B Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
12/01/2010CN1886133B Indole compounds
12/01/2010CN1878786B Novel 17beta-hydroxysteroid dehydrogenase type I inhibitors
12/01/2010CN1872074B Compound drop pills of 'Huangtangning', and preparation method
12/01/2010CN1872073B Drop pills of oleanolic acid, and preparation method
1 ... 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 ... 7860